Latest Medical News3 Min Read UmeshonFebruary 12, 2026 Papzimeos: First FDA-Approved Immunotherapy for Recurrent Respiratory Papillomatosis The FDA approves Papzimeos (zopapogene imadenovec-drba), the first immunotherapy for recurrent respiratory papillomatosis, offering new hope… Discover More
